A1 Refereed original research article in a scientific journal

Investigative assessment of the neuro-modulatory potentials of cannabichromene in TrkB/BDNF-mediated neurosignaling pathway




AuthorsDosumu, Oluwatosin Adebisi; Taiwo, Odunayo Anthonia; Akomolafe, Victoria Omoyemi; Oni, Eniola Oluwayemisi; Ojo, Oluwafemi Adeleke; Dedeke, Gabriel Adewunmi; Ademuyiwa, Oladipo

PublisherSpringer Science and Business Media LLC

Publication year2025

JournalComparative Clinical Pathology

Journal name in sourceComparative Clinical Pathology

ISSN1618-5641

eISSN1618-565X

DOIhttps://doi.org/10.1007/s00580-025-03659-w

Web address https://doi.org/10.1007/s00580-025-03659-w


Abstract
Cannabichromene (CBC) is the third most abundant non-psychoactive cannabinoid found in Cannabis sativa. It is reported to be responsible for some effects in users, ranging from psychological, neurodevelopmental, teratogenic to reproductive toxicity. Consequently, experimental evaluation of the mechanism of action and interaction seemed paramount. Therefore, this work determined the mechanism through which cannabichromene modulates neurosignaling using computational analysis and various biochemical investigative approaches. The effects of 3 weeks oral administration of 10 mg/kg body weight dose of CBC on some neurodevelopment biomarkers in the hippocampus and striatum of young male and female Wistar rats were investigated. Induced fit docking scores revealed that cannabichromene had the highest binding scores with tropomyosin receptor kinase B (TrkB) (− 797.23 kJ/mol)when compared with other cannabinoids. It also formed hydrogen bonds with amino acids GLU634, MET636 at the active site of the protein, thereby contributing to the stability of the protein–ligand complex. Neurosignaling enzymes (acetylcholinesterase (AChE) and monoamine oxidase MAO-A) activities were significantly (p < 0.05) increased in the CBC-exposed groups as well as malondialdehyde (MDA) concentration. Relative expressions of brain-derived neurotropic factor (BDNF) and dopamine receptor 1 (DR1) genes were significantly (p < 0.05) downregulated in the CBC groups relative to control, all indicative of a compromised neurosignaling mechanism. Furthermore, behavioral cognitive biomarkers, discrimination ratio (DR), and difference scores (DS) were significantly altered in the test animals, suggestive of impairment in short-term memory. Histological evaluations revealed aberrant histoarchitecture of brain tissues in CBC-exposed rats, characterized by congestion of the cortical capillaries, degeneration of neuronal cells, and focal gliosis. It may be deduced from this study that cannabichromene impaired hippocampal and striatal neurotransmission in adolescents by altering neurotransmitter dynamics, neuronal morphology, and gene expression, with potential implications for cognitive dysfunction and neurodegeneration.


Funding information in the publication
This research received no external funding.


Last updated on 2025-06-06 at 08:33